The findings identify a significant antihypertensive effect of H4R agonism in the SHR and CUMS‐induced hypertensive rats, and suggest a potential therapeutic target for hypertension, particularly neurogenic and sympathetically driven forms. Here, HRH4 is linked to hypertensive disorder.